Skip to content

Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, sold ORKA on Aug 13, 2026

Data as of Oct 16

▼ SELL$231K2,142 shares at $107.71Arjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.
Watch ORKA
Traded
Aug 13, 2026
Disclosed
Aug 14, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, sold ORKA on Aug 13, 2026TRADEDDISCLOSED
ORKASimilar stocks (XLV — its sector index fund), rebased to ORKA's price on the disclosure day
ORKA since disclosure
−35.2%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Aug 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$225Kdisclosed Aug 14 · filed 1 day after the trade
  2. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$220Kdisclosed Aug 14 · filed 1 day after the trade
  3. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$256Kdisclosed Aug 14 · filed 1 day after the trade
  4. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$135Kdisclosed Aug 14 · filed 1 day after the trade

See every trade on ORKA →